OCC 20.9% 66.5¢ orthocell limited

Further CelGro® nerve clinical trial data from all patients at 12 months, page-107

  1. 790 Posts.
    lightbulb Created with Sketch. 126
    I like reading comments that question aspects of the company if they are legitimate queries and your posts are always worth reading. The ones who are just bagging the company with no legitimate reason or are deliberately trying to down ramp are the ones i don't like. I understand it can be frustrating at times but rants like galaxycar has are annoying.
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.